<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="144794">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02126085</url>
  </required_header>
  <id_info>
    <org_study_id>SIESTA</org_study_id>
    <nct_id>NCT02126085</nct_id>
  </id_info>
  <brief_title>Sedation vs. Intubation for Endovascular Stroke TreAtment</brief_title>
  <acronym>SIESTA</acronym>
  <official_title>Sedation vs. Intubation for Endovascular Stroke TreAtment</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital Heidelberg</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital Heidelberg</source>
  <oversight_info>
    <authority>Germany: Ethics Commission</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Sedation vs Intubation for Endovascular Stroke TreAtment Trial (SIESTA) is a prospective,
      randomised controlled, monocentric, two-armed, comparative trial. Patients are randomized 1
      : 1 to	either non-intubated state or to intubated state for endovascular stroke treatment.
      Otherwise, no principal differences in intensive care treatment are intended, and standard
      operating procedures are applied to ensure uniform management decisions in fields such as
      ventilation, sedation, cardio-vascular and cerebral monitoring and management.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Early recanalization is an important, if not the most important, factor concerning
      reconstitution of patients´ health in ischaemic stroke. This is the reason why patients with
      extended stroke are increasingly subjected to an endovascular stroke therapy (EST).

      Matter of ongoing debate is how to sedate these patients during intervention. Some
      clinicians prefer an intubation due to a reduction of patients´movements and therefore
      potentially lowering complication rates (injury by catheter, aspiration e.g.).

      On the other hand retrospective investigations hypothesize that general anaesthesia is
      associated with peri-interventional hypotension followed by poorer clinical outcome.

      The best anaesthaesiologic management in endovascular stroke therapy to this point of time
      is not known. The investigators therefore designed this study comparing intubated state with
      general anaesthesia vs. non-intubated state with conscious sedation during EST, focusing on
      patients´ outcome.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>April 2014</start_date>
  <completion_date type="Anticipated">June 2016</completion_date>
  <primary_completion_date type="Anticipated">March 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>National Institutes of Health Stroke Scale (NIHSS) after 24 hours</measure>
    <time_frame>24 hours</time_frame>
    <safety_issue>No</safety_issue>
    <description>Neurological improvement of NIHSS 24 hours after intervention</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Outcome after 3 month using the modified Rankin Scale (mRS)</measure>
    <time_frame>3 month</time_frame>
    <safety_issue>No</safety_issue>
    <description>Assessing the neurological outcome after 3 months with the mRS.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Inpatient-mortality</measure>
    <time_frame>Mortality-rate until timepoint of discharge, an expected average of 3 weeks.</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mortality-rate within the first 3 months after intervention.</measure>
    <time_frame>First 3 months after intervention</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <other_outcome>
    <measure>Duration of hospital stay</measure>
    <time_frame>Participants will be followed until timepoint of discharge, an expected average of 3 weeks.</time_frame>
    <safety_issue>No</safety_issue>
  </other_outcome>
  <other_outcome>
    <measure>Periinterventional complications</measure>
    <time_frame>Evaluation of Adverse Events as a Measure of Safety and Tolerability until timepoint of discharge, an expected average of 3 weeks.</time_frame>
    <safety_issue>No</safety_issue>
  </other_outcome>
  <other_outcome>
    <measure>Achieved recanalisation grade</measure>
    <time_frame>Duration of intervention with an expected average of 2 hours</time_frame>
    <safety_issue>No</safety_issue>
    <description>Recanalisation status is classified according to the Thrombolysis in Cerebral Infarction classification (TICI).</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Acute Ischemic Stroke</condition>
  <arm_group>
    <arm_group_label>Intubation</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Intubation and invasive mechanical ventilation + endovascular recanalisation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>No Intubation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Conscious sedation and non-invasive ventilatory support + endovascular recanalisation</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Endovascular recanalisation</intervention_name>
    <description>Endovascular recanalisation by mechanical thrombectomy with e.g. stent retriever device, possibly following intravenous thrombolysis within a &quot;bridging concept&quot;</description>
    <arm_group_label>Intubation</arm_group_label>
    <arm_group_label>No Intubation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age ≥18 years

          -  acute stroke in anterior circulation

          -  occlusion of carotid artery and/ or middle cerebral artery

          -  planned mechanical recanalisation

          -  informed consent from patient or legal representative

        Exclusion Criteria:

          -  age &lt; 18 years

          -  informed consent not obtainable

          -  coma

          -  agitation

          -  vomiting

          -  difficult airway management

          -  additional cerebral hemorrhage
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Julian Bösel, PD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Neurology, University Hospital Heidelberg</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Silvia Schönenberger, Dr.</last_name>
    <phone>0049-6221-5637549</phone>
    <email>silvia.schoenenberger@med.uni-heidelberg.de</email>
  </overall_contact>
  <location>
    <facility>
      <name>Department of Neurology, University Hospital Heidelberg</name>
      <address>
        <city>Heidelberg</city>
        <state>Baden-Württemberg</state>
        <zip>69120</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Silvia Schönenberger, Dr.</last_name>
      <phone>0049-6221-5637549</phone>
      <email>silvia.schoenenberger@med.uni-heidelberg.de</email>
    </contact>
    <investigator>
      <last_name>Silvia Schönenberger, Dr.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <reference>
    <citation>Lees KR, Bluhmki E, von Kummer R, Brott TG, Toni D, Grotta JC, Albers GW, Kaste M, Marler JR, Hamilton SA, Tilley BC, Davis SM, Donnan GA, Hacke W; ECASS, ATLANTIS, NINDS and EPITHET rt-PA Study Group, Allen K, Mau J, Meier D, del Zoppo G, De Silva DA, Butcher KS, Parsons MW, Barber PA, Levi C, Bladin C, Byrnes G. Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials. Lancet. 2010 May 15;375(9727):1695-703. doi: 10.1016/S0140-6736(10)60491-6.</citation>
    <PMID>20472172</PMID>
  </reference>
  <reference>
    <citation>Rha JH, Saver JL. The impact of recanalization on ischemic stroke outcome: a meta-analysis. Stroke. 2007 Mar;38(3):967-73. Epub 2007 Feb 1.</citation>
    <PMID>17272772</PMID>
  </reference>
  <reference>
    <citation>Nogueira RG, Liebeskind DS, Sung G, Duckwiler G, Smith WS; MERCI; Multi MERCI Writing Committee. Predictors of good clinical outcomes, mortality, and successful revascularization in patients with acute ischemic stroke undergoing thrombectomy: pooled analysis of the Mechanical Embolus Removal in Cerebral Ischemia (MERCI) and Multi MERCI Trials. Stroke. 2009 Dec;40(12):3777-83. doi: 10.1161/STROKEAHA.109.561431. Epub 2009 Oct 29.</citation>
    <PMID>19875740</PMID>
  </reference>
  <reference>
    <citation>Bösel J, Hacke W, Bendszus M, Rohde S. Treatment of acute ischemic stroke with clot retrieval devices. Curr Treat Options Cardiovasc Med. 2012 Jun;14(3):260-72. doi: 10.1007/s11936-012-0172-y.</citation>
    <PMID>22392611</PMID>
  </reference>
  <reference>
    <citation>McDonagh DL, Olson DM, Kalia JS, Gupta R, Abou-Chebl A, Zaidat OO. Anesthesia and Sedation Practices Among Neurointerventionalists during Acute Ischemic Stroke Endovascular Therapy. Front Neurol. 2010 Nov 11;1:118. doi: 10.3389/fneur.2010.00118. eCollection 2010.</citation>
    <PMID>21188256</PMID>
  </reference>
  <reference>
    <citation>Davis MJ, Menon BK, Baghirzada LB, Campos-Herrera CR, Goyal M, Hill MD, Archer DP; Calgary Stroke Program. Anesthetic management and outcome in patients during endovascular therapy for acute stroke. Anesthesiology. 2012 Feb;116(2):396-405. doi: 10.1097/ALN.0b013e318242a5d2.</citation>
    <PMID>22222475</PMID>
  </reference>
  <verification_date>April 2014</verification_date>
  <lastchanged_date>April 29, 2014</lastchanged_date>
  <firstreceived_date>April 23, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital Heidelberg</investigator_affiliation>
    <investigator_full_name>Dr. Silvia Schönenberger, MD</investigator_full_name>
    <investigator_title>Leading sub-investigator, Principal Investigator: PD Dr. Julian Bösel, MD</investigator_title>
  </responsible_party>
  <keyword>ischemic stroke</keyword>
  <keyword>recanalisation</keyword>
  <keyword>sedation</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Ischemia</mesh_term>
    <mesh_term>Stroke</mesh_term>
    <mesh_term>Cerebral Infarction</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
